Our present work shows MLN4924-treated lung cancer cells had lower gene expression of CCL2 and CSF1 (data not shown) than controls, suggesting that CCL2, CSF1 may participate in modulating the TAM infiltration in LUAD. The gene discussed is CSF1; the disease is lung carcinoma.